Brief: Advicenne Announces Partly Recovery From Growth Retardation After Control Of Metabolic Acidosis With ADV-7103

Advicenne SA

05/04/2022 17:24

April 5 (Reuters) - Advicenne SA  ALDVI.PA :
    * ANNOUNCES A CASE REPORT PUBLISHED IN JOURNAL OF NEPHROLOGY
ABOUT
A CHILD PARTLY RECOVERING FROM GROWTH RETARDATION RESULTING FROM
THE LONG-TERM CONTROL OF HER METABOLIC ACIDOSIS WITH ADV-7103
    * THIS CASE SUPPORTS THE INTEREST OF ADV-7103 IN THE
TREATMENT OF
DRTA AND THE LONG-TERM ADVANTAGE OF A BI-DAILY DOSING COMPARED
TO THE USUAL MANAGEMENT OF THIS DISEASE

Source text for Eikon:  urn:newsml:reuters.com:*:nBw4R50R3a
Further company coverage:  ALDVI.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 772 09 20;))